11/14
02:37 pm
scph
scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
11/14
01:34 pm
scph
scPharmaceuticals Inc. (NASDAQ: SCPH) had its price target lowered by analysts at Craig Hallum from $16.00 to $12.00. They now have a "buy" rating on the stock.
Low
Report
scPharmaceuticals Inc. (NASDAQ: SCPH) had its price target lowered by analysts at Craig Hallum from $16.00 to $12.00. They now have a "buy" rating on the stock.
11/13
04:01 pm
scph
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
11/6
04:01 pm
scph
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
Low
Report
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
10/15
08:30 am
scph
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024
Low
Report
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024
9/4
04:05 pm
scph
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Low
Report
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference